Product logins

Find logins to all Clarivate products below.


Trauma Devices | Market Insights | Japan | 2023

Given the urgent nature of the procedures, the Japanese trauma device market was impacted less severely by the COVID-19 pandemic. Going forward, favorable demographics and increasing presence of the domestic competitors will support market growth; however, the possible introduction of a cost-effectiveness–based reimbursement pricing system, slower entry of premium-priced devices relative to other mature markets globally, and falling ASPs—reflecting biennial MHLW reimbursement cuts—will hinder overall revenue growth.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for trauma devices in Japan from 2019 through 2031.

Related Medtech Insights Reports

Report
Sports Medicine Devices – Market Insights – Japan
Technological investments, adoption of premium-priced products, increased market awareness through educational programs, improved surgeon training, and high levels of sports participation will…
Report
Large-Joint Reconstructive Implants – Market Insights – Japan
Growth in large-joint reconstructive procedure volumes is being driven by favorable demographic trends and increased demand for innovative technologies. However, market expansion is partly…
Report
Trauma Devices – Market Insights – Japan
The Japanese trauma device market will experience marginal growth through 2034, primarily fueled by the adoption of innovative, premium-priced technologies. This upward trend is further supported…
Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Japan
The Japanese GI endoscopy device market is projected to experience modest expansion through 2034. This growth is driven by favorable treatment and screening guidelines, as well as an aging…